The course forward: next generation sequencing as part of the next generation management of patients with locally advanced cervical cancer

J Gynecol Oncol. 2022 Jan;33(1):e20. doi: 10.3802/jgo.2022.33.e20.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Disease-Free Survival
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Hysterectomy
  • Uterine Cervical Neoplasms* / surgery